1. Home
  2. VRDN vs TPB Comparison

VRDN vs TPB Comparison

Compare VRDN & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • TPB
  • Stock Information
  • Founded
  • VRDN 2006
  • TPB 1988
  • Country
  • VRDN United States
  • TPB United States
  • Employees
  • VRDN N/A
  • TPB N/A
  • Industry
  • VRDN Medical Specialities
  • TPB Tobacco
  • Sector
  • VRDN Health Care
  • TPB Consumer Discretionary
  • Exchange
  • VRDN Nasdaq
  • TPB Nasdaq
  • Market Cap
  • VRDN 1.6B
  • TPB 1.6B
  • IPO Year
  • VRDN N/A
  • TPB 2016
  • Fundamental
  • Price
  • VRDN $23.63
  • TPB $89.90
  • Analyst Decision
  • VRDN Strong Buy
  • TPB Strong Buy
  • Analyst Count
  • VRDN 10
  • TPB 5
  • Target Price
  • VRDN $36.78
  • TPB $77.00
  • AVG Volume (30 Days)
  • VRDN 1.5M
  • TPB 347.1K
  • Earning Date
  • VRDN 11-13-2025
  • TPB 11-05-2025
  • Dividend Yield
  • VRDN N/A
  • TPB 0.33%
  • EPS Growth
  • VRDN N/A
  • TPB N/A
  • EPS
  • VRDN N/A
  • TPB N/A
  • Revenue
  • VRDN $305,000.00
  • TPB $407,441,000.00
  • Revenue This Year
  • VRDN N/A
  • TPB $24.45
  • Revenue Next Year
  • VRDN $34,044.63
  • TPB $8.46
  • P/E Ratio
  • VRDN N/A
  • TPB $37.11
  • Revenue Growth
  • VRDN 5.90
  • TPB 37.09
  • 52 Week Low
  • VRDN $9.90
  • TPB $46.36
  • 52 Week High
  • VRDN $27.20
  • TPB $104.76
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 62.01
  • TPB 47.67
  • Support Level
  • VRDN $21.65
  • TPB $86.71
  • Resistance Level
  • VRDN $24.23
  • TPB $90.84
  • Average True Range (ATR)
  • VRDN 1.11
  • TPB 3.53
  • MACD
  • VRDN -0.03
  • TPB 0.32
  • Stochastic Oscillator
  • VRDN 68.07
  • TPB 63.92

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About TPB Turning Point Brands Inc.

Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.

Share on Social Networks: